Global Bariatric Surgery Devices Industry: Market Size & Forecast 2026

The global bariatric surgery devices market includes a wide range of products such as surgical staplers, gastric bands, intragastric balloons, gastric remodeling systems, tissue apposition devices, and various endoscopic instruments used in metabolic bariatric surgery. Industry estimates project nearly 1.1 million bariatric procedures performed globally by 2025, generating substantial demand for associated medical devices across hospital and ambulatory surgical settings. While anti-obesity medications have scaled significantly into 2025 and beyond, surgical devices continue to serve as essential interventions for severe obesity cases where pharmaceutical treatments are insufficient or unsuitable.

• •Market valued at approximately $2.55 billion in 2025 with a projected CAGR of 6.42%
• •Nearly 1.1 million bariatric procedures performed globally annually, driving consistent device demand
• •Device portfolio spans stapling instruments, gastric bands, balloons, endoscopic systems, and tissue apposition technologies

The global obesity epidemic remains the primary engine of market growth, with obesity rates continuing to rise through 2025 and 2030 across both developed and developing regions, expanding the pool of eligible surgical candidates. Advances in metabolic bariatric surgery and endoscopic therapies, including FDA-cleared gastric remodeling and tissue apposition devices, have broadened the scope of treatable patients and improved procedural safety profiles. The structural demand from aging demographics and the growing clinical evidence for long-term positive outcomes following bariatric surgery reinforce sustained adoption of these devices worldwide.

• •Rising global obesity rates expanding the addressable patient population eligible for bariatric intervention
• •Technological advances in endoscopic bariatric therapies and minimally invasive platforms widening clinical applications
• •Growing long-term outcome data supporting bariatric surgery efficacy driving physician and patient confidence

The market is segmented across surgical staplers, gastric bands, intragastric balloons, endoscopic bariatric devices, and associated accessories, with endoscopic and minimally invasive technologies representing the fastest-growing product categories. North America commands the largest regional share due to high obesity prevalence, established reimbursement frameworks, and advanced healthcare infrastructure supporting bariatric surgery programs. Asia-Pacific is emerging as a high-growth region driven by rising obesity rates, expanding healthcare access, and increasing medical tourism for bariatric procedures, while Europe maintains a steady presence shaped by regulatory standards and widespread surgical adoption.

• •Product segments include staplers, adjustable gastric bands, intragastric balloons, endoscopic systems, and access instruments
• •North America leads in market share, supported by high obesity prevalence and mature reimbursement infrastructure
• •Asia-Pacific is the fastest-growing region, driven by rising obesity rates, improved healthcare access, and medical tourism

What are the recent trends and outlook?

The market is trending strongly toward minimally invasive and endoscopic bariatric therapies as an alternative to traditional surgical approaches, with FDA-cleared endoscopic devices gaining clinical traction and structural market share through 2030. Robotic-assisted bariatric surgery and digital integration into pre- and post-operative care pathways represent emerging directions, though conventional surgical stapling remains dominant for complex procedures. The coexistence of pharmaceutical anti-obesity treatments and surgical devices is expected to persist, with each modality serving distinct patient populations and clinical indications as the global response to obesity continues to evolve.

• •Growing shift toward endoscopic bariatric therapies and minimally invasive alternatives to open surgical procedures
• •Robotic-assisted platforms and digital health integration emerging as next-generation developments in the field
• •Long-term outlook through 2030 remains positive, with continued demand supported by persistent global obesity prevalence